Selection Criteria for Onboarding SPEP/IFE and Helena Touch Series as Our Solution

Tuesday, July 26
6 – 7:30 p.m.
Hyatt Regency, Regency Ballroom CD
Sponsored by Helena Labs


Join faculty as they showcase an in-depth study into why Tennessee Oncology chose the Helena Laboratories Electrophoresis System and software to easily monitor myeloma patients.


After attending this session, participants will be able to:

  • Describe how Helena’s SPEP/IFE system streamlines interpretation of tracking myeloma patients.
  • Discuss the beneficial financial and time management outcomes of using the software in the laboratory.



Robert S. Galen, MD, MPH
Professor Emeritus, College of Public Health - University of Georgia
Athens, GA


Douglas Kingma, MD
Medical Director, Tennessee Oncology
Nashville, TN